The struggling healthcare firm says it wants to move away from its extremely expensive corporate head office model, eyeing a structure more like an investment holding company, seeking to decentralise management and inculcate transparency and accountability.
Neethling, who will earn R1 a month as acting CEO, has also been appointed as chief transition officer, tasked with a rapid transformation of a group still trying to put its debt problems behind it.
/PRNewswire/ The "South African Cough, Cold and Flu Remedies Industry Landscape Report 2022" report has been added to ResearchAndMarkets.com s offering..